Therapeutic rationale for mTOR inhibition in advanced renal cell carcinoma.

Husseinzadeh HD, Garcia JA. Therapeutic rationale for mTOR inhibition in advanced renal cell carcinoma. Curr Clin Pharmacol. 2011 Aug; 6(3):214-21.

View in: PubMed